Mitigation of evolved bacterial resistance to phage therapy - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles (Review Article) Current Opinion in Virology Year : 2022

Mitigation of evolved bacterial resistance to phage therapy

Abstract

The ease with which bacteria can evolve resistance to phages is a key consideration for development of phage therapy. Here, we review recent work on the different evolutionary and ecological approaches to mitigate the problem. The approaches are broadly categorised into two areas: Minimising evolved phage resistance; and Directing phage-resistance evolution towards therapeutically beneficial outcomes.
Fichier principal
Vignette du fichier
2022_Torres-Barcelo_Curr-Opin-Virol_postprint.pdf (4.48 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Licence : CC BY NC ND - Attribution - NonCommercial - NoDerivatives

Dates and versions

hal-03586641 , version 1 (03-03-2022)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

Clara Torres-Barceló, Paul E Turner, Angus Buckling. Mitigation of evolved bacterial resistance to phage therapy. Current Opinion in Virology, 2022, 53, pp.101201. ⟨10.1016/j.coviro.2022.101201⟩. ⟨hal-03586641⟩
59 View
167 Download

Altmetric

Share

Gmail Facebook X LinkedIn More